I’ve cried a lot lately. Last week was one of the best though.
My surgery was June 5 and by all accounts went well. That was a big step. Even though I know the odds, I created these crazy scenarios of rare disastrous outcomes. This experience has been characterized by a rollercoaster of events and outcomes.
Last week, when my pathology report came back, it was a big event. When I got the MyChart notification I was paralyzed. (I’ve now moved MyChart to my phone home screen and allow it to notify me at will - giving it an unearned power.) Although I had waited for days for this report, I couldn’t even read it. My heart raced. My breathing stopped. Paralyzed. This was the big moment. I knew that a few of the tumors like mine could be completely cured surgically. On the other hand, most of them would hang around like a cloud over you and be an ever-present threat.
The news was good! I should be cured! It took a while to set in. Then I broke down with tears of joy.
The only other crying episode that perhaps vies for the top position is when I first looked at my completely shaved, old man’s, pale white, flabby muffin top for the first time after the surgery. That required a healthy sense of humor.
As I’ve said before, through this diagnosis I was graciously given an expanded range of emotions and a set of mystifying and cherished experiences that I now share with others who have been diagnosed with cancer. But I want to recognize that not all are as fortunate as I have been. In light of that, I am proud to lead a group of people who come to work each day on behalf of patients with cancer and numerous other physical and mental illnesses and that we touch their lives and the lives of those around them in profound ways.
We are at the mercy of our health. The privilege we all have to care for those in times of greatest need should be respected and cherished. We all serve under a remarkable calling.
Partners in Health
A new, collaborative branding initiative will highlight the unique partnership between CU Anschutz and UCHealth bringing world-class research and advanced treatments to our multi-state region, leading to excellent outcomes for our patients.
The concept is simple yet impactful: Partners in Health.

In areas that are explicitly tied to academic medicine and that are unique to CU Anschutz and UCHealth, including transplant, advanced cancer treatments, personalized medicine, and ophthalmology services, UCHealth and CU Anschutz will jointly produce advertising and other marketing programs with the goal of communicating the benefits our partnership is delivering.
At the heart of this initiative is our academic-clinical partnership — what sets us apart. Together, CU Anschutz and UCHealth bring the full strength of academic medicine to our communities, advancing scientific breakthroughs, training the next generation of health professionals, and providing exceptional care. Grounded in the latest research and clinical trials, we drive better outcomes for those we serve while setting the standard of care. Through this effort, we will tell that story.
Leaders will share more with you over the coming months as we develop the co-branded initiative and build a landing page where our patients and the public can learn more about the benefits UCHealth and CU Anschutz — and our important partnership — bring to this region.
Faculty Connection, Leadership Development, and Coaching
The School of Medicine is currently recruiting faculty for two innovative research studies through CU Thrive: Center for Workplace Well-Being Research. Faculty can participate in either ThriveCircles, a peer-led program focused on connection, belonging, and professional well-being, or Thrive Leadership Circles, a leadership development program designed to strengthen supportive leadership practices and improve team well-being. Both studies include facilitated discussions, shared meals, and compensation for participation.
In addition, School of Medicine faculty have access to our CU Thrive: Office for Well-being Faculty Coaching Program, which provides confidential coaching to help faculty reconnect with purpose, navigate challenges, enhance professional fulfillment, and support overall well-being.
Learn more and enroll:

Read More About the Pivotal Partnership

Ann D. Thor, MD, Chair of Pathology, has been named a recipient of the AAPath Distinguished Service Award at this year’s Annual Meeting of the Association for Academic Pathology, which will be held in Boston in July. The award recognizes lifetime achievement in the field of academic pathology, encompassing the full spectrum of contributions at the local and national levels in undergraduate and graduate medical education, research, and clinical service.

Tamara K. Oser, MD, Professor of Family Medicine, is the Principal Investigator for a landmark research trial, “CGM for Adults with Type 2 Diabetes Not on Insulin: The CONNECT Randomized Controlled Trial.” Results were presented on June 6 at the 2026 Scientific Sessions of the American Diabetes Association in New Orleans.
2026 Translational Research Scholars
The School of Medicine Program to Advance Physician Scientists & Translational Research announced this year’s Translational Research Scholars. The program fosters translational research among early career faculty who are within the first four years of their assistant professor appointment. Each scholar receives up to $300,000 over four years to support their research. This year’s scholars are listed below. You can learn more about their projects on the 2026 Translational Research Scholars webpage.
CU Anschutz Federal Research Update Town Hall
Wednesday, June 17, 7:30–8 a.m.
Thursday, July 9
Donald Elliman Conference Center, Anschutz Health Sciences Building
The Department of Pharmacology released a new video featuring department chair, Heide Ford, PhD, giving a broad overview of the department's work. Watch the full video to hear how the faculty and researchers are driving this foundational science.Now Hiring: Senior Associate Dean for AI and Health Data Science
The School of Medicine is recruiting a Senior Associate Dean for AI and Health Data Science to provide strategic leadership for artificial intelligence, data governance, and health data science. Reporting to the Dean, this role will lead development and execution of the school’s AI and data strategy; advance AI-enabled innovation across research, clinical care, education, and operations; and align institutional efforts with health system and university partners. The Senior Associate Dean will oversee a portfolio of data, informatics, and information units; build shared services and capabilities that support faculty, learners, and leaders; and promote the responsible, equitable, and effective use of AI. This role will shape how AI and health data science strengthen academic medicine, improve care and learning, and expand the school’s institutional impact. The job description includes details about the position and application instructions.
Have a good week,

John H. Sampson, MD, PhD, MBA
Richard D. Krugman Endowed Chair
Vice Chancellor for Health Affairs and
Dean, University of Colorado Anschutz School of Medicine
The Dean’s weekly message is an email news bulletin from John H. Sampson, MD, PhD, MBA, Dean of the CU Anschutz School of Medicine, that is distributed to inform CU Anschutz School of Medicine faculty members, staff, students and others about issues pertaining to the school’s mission of education, research, clinical care and community service.
Subscribe to the Dean's Message